NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 14707079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

  2003cited by this paper
• Caspase Activity Is Required for Stimulated B Lymphocytes to Enter the Cell Cycle1

  2003cited by this paper
• Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms.

  2003cited by this paper
• Yin Yang 1 Is a Lipopolysaccharide-Inducible Activator of the Murine 3′ Igh Enhancer, hs3 1

  2003cited by this paper
• The immunoglobulin heavy-chain locus hs3b and hs4 3' enhancers are dispensable for VDJ assembly and somatic hypermutation.

  2003cited by this paper
• Cutting Edge: CD40 Engagement Eliminates the Need for Bruton’s Tyrosine Kinase in B Cell Receptor Signaling for NF-κB1

  2003cited by this paper
• The Interaction of Pax5 (BSAP) with Daxx Can Result in Transcriptional Activation in B Cells*

  2002cited by this paper
• Molecular cytogenetic characterization of non‐Hodgkin lymphoma cell lines

  2002cited by this paper
• NF-kappaB regulation in the immune system.

  2002cited by this paper
• Expression of transcription factors Pu.1, Spi‐B, Blimp‐1, BSAP and oct‐2 in normal human plasma cells and in multiple myeloma cells

  2002cited by this paper
• HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.

  2001cited by this paper
• Localization of the 3' IgH locus elements that effect long-distance regulation of class switch recombination.

  2001cited by this paper
• Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-κB control

  2001cited by this paper
• Unique Function for Carboxyl-Terminal Domain of Oct-2 in Ig-Secreting Cells1

  2001cited by this paper
• Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM

  2001cited by this paper
• Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia

  2001cited by this paper
• Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells

  2001cited by this paper
• A Pivotal Role for DNase I-Sensitive Regions 3b and/or 4 in the Induction of Somatic Hypermutation of IgH Genes1

  2001cited by this paper
• CD40: CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes

  2001cited by this paper
• Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response

  2000cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• The language of covalent histone modifications

  2000cited by this paper
• TRANSFAC: an integrated system for gene expression regulation

  2000cited by this paper
• Interaction and functional interference of C / EBPβ with octamer factors in immunoglobulin gene transcription

  2000cited by this paper
• Regulation of the promoter for human immunoglobulin γ3 germ‐line transcription and its interaction with the 3'α enhancer

  2000cited by this paper
• Role of OCA-B in 3′-IgH Enhancer Function1

  2000cited by this paper
• Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.

  2000cited by this paper
• Acetylation of Histones and Transcription-Related Factors

  2000cited by this paper
• NF-κB Activity Is Required for the Deregulation of c-myc Expression by the Immunoglobulin Heavy Chain Enhancer*

  2000cited by this paper
• Regulation of germline promoters by the two human Ig heavy chain 3' alpha enhancers.

  2000cited by this paper
• Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas.

  2000cited by this paper
• Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.

  2000cited by this paper
• Differential regulation of CD40-mediated human B cell responses by antibodies directed against different CD40 epitopes.

  2000cited by this paper
• The 3' IgH regulatory region: a complex structure in a search for a function.

  2000cited by this paper
• Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key?

  1999cited by this paper
• Temporal expression of a V(H) promoter-Cmu transgene linked to the IgH HS1,2 enhancer.

  1999cited by this paper
• Transcriptional regulation of the murine 3' IgH enhancer by OCT-2.

  1999cited by this paper
• NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

  1998cited by this paper
• Class Switching in B Cells Lacking 3′ Immunoglobulin Heavy Chain Enhancers

  1998cited by this paper
• The Immunoglobulin Heavy Chain Locus Control Region Increases Histone Acetylation along Linked c-myc Genes

  1998cited by this paper
• Coactivator OBF-1 Makes Selective Contacts with Both the POU-Specific Domain and the POU Homeodomain and Acts as a Molecular Clamp on DNA

  1998cited by this paper
• Synergies between regulatory elements of the immunoglobulin heavy chain locus and its palindromic 3 ′ locus control region

  1998cited by this paper
• OCA‐B integrates B cell antigen receptor‐, CD40L‐ and IL 4‐mediated signals for the germinal center pathway of B cell development

  1998cited by this paper
• Identification of a homolog of the C alpha 3'/hs3 enhancer and of an allelic variant of the 3'IgH/hs1,2 enhancer downstream of the human immunoglobulin alpha 1 gene.

  1997cited by this paper
• The enhancer shift: a model to explain the developmental control of IgH gene expression in B-lineage cells.

  1997cited by this paper
• Murine and human 3'IgH regulatory sequences.

  1997cited by this paper
• Cell-type and Tissue-specific Expression of Caveolin-2

  1997cited by this paper
• Enhancer Complexes Located Downstream of Both Human Immunoglobulin Cα Genes

  1997cited by this paper
• A soluble transcription factor, Oct-1, is also found in the insoluble nuclear matrix and possesses silencing activity in its alanine-rich domain

  1996cited by this paper
• Identification of 3' alpha-hs4, a novel Ig heavy chain enhancer element regulated at multiple stages of B cell differentiation.

  1995cited by this paper
• Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses.

  1995cited by this paper
• Oct-2 is required early in T cell-independent B cell activation for G1 progression and for proliferation.

  1994cited by this paper
• Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.

  1994cited by this paper
• V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer.

  1993cited by this paper
• CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome

  1993cited by this paper
• Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus.

  1993cited by this paper
• Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.

  1992cited by this paper
• Ethidium bromide provides a simple tool for identifying genuine DNA-independent protein associations.

  1992cited by this paper
• Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site.

  1991cited by this paper
• The plasmacytoma J558L lacks constitutively active NF-kappa B and is deficient in early response gene activation.

  1991cited by this paper
• Differential transcriptional activation by Oct-1 and Oct-2: interdependent activation domains induce Oct-2 phosphorylation.

  1990cited by this paper
• Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

  1989cited by this paper
• Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility.

  1987cited by this paper
• Distinct factors bind to apparently homolgous sequences in the immunoglobulin heavy-chain enhancer

  1986cited by this paper
• Multiple nuclear factors interact with the immunoglobulin enhancer sequences.

  1986cited by this paper

• The Conserved Network of NF-κB Transcriptional Partners from Drosophila to Mammals.

  2025cites this paper
• Deletion of the mRNA endonuclease Regnase-1 promotes NK cell anti-tumor activity via OCT2-dependent transcription of Ifng.

  2024cites this paper
• IκBζ is a dual-use coactivator of NF-κB and POU transcription factors.

  2024cites this paper
• Yin Yang 1 expression predicts a favourable survival in diffuse large B-cell lymphoma

  2024cites this paper
• Evolutive emergence and divergence of an Ig regulatory node: An environmental sensor getting cues from the aryl hydrocarbon receptor?

  2023cites this paper
• Zinc Ions Modulate YY1 Activity: Relevance in Carcinogenesis

  2023cites this paper
• Genome Instability in Multiple Myeloma: Facts and Factors

  2021cites this paper
• From Influenza Virus Infections to Lupus: Synchronous Estrogen Receptor α and RNA Polymerase II Binding Within the Immunoglobulin Heavy Chain Locus

  2020cites this paper
• Antimyeloma Potential of Caffeic Acid Phenethyl Ester and Its Analogues through Sp1 Mediated Downregulation of IKZF1-IRF4-MYC Axis.

  2020cites this paper
• YY1 regulates cancer cell immune resistance by modulating PD-L1 expression.

  2019cites this paper
• RelB acts as a molecular switch driving chronic inflammation in glioblastoma multiforme

  2019cites this paper
• Characterising heterogeneous TRAIL responsiveness and overcoming TRAIL resistance in multicellular tumour spheroids

  2018cites this paper
• Discovery platform for inhibitors of IgH gene enhancer activity

  2018cites this paper
• miR-29a suppresses IL-13-induced cell invasion by inhibiting YY1 in the AKT pathway in lung adenocarcinoma A549 cells

  2018cites this paper
• BET proteins are a key component of immunoglobulin gene expression

  2017cites this paper
• The Role of Transcription Factor YY1 in the Biology of Cancer.

  2017cites this paper
• A FUNCTIONAL ANALYSIS OF THE 3’ REGULATORY REGION OF THE IMMUNOGLOBULIN HEAVY CHAIN GENE

  2016cites this paper
• Species Differences in the Effects of TCDD on a Transcriptional RegulatoryRegion within the Ig Heavy Chain Gene

  2016influential citation
• Differential Effects of The AhR on Immunoglobulin Gene Expression in Human B Cells

  2015cites this paper
• Long-Range Modulation of PAG1 Expression by 8q21 Allergy Risk Variants.

  2015cites this paper
• Elucidating the effects of TCDD on the polymorphic human hs1,2 enhancer .

  2014cites this paper
• Yin Yang 1 Is a Repressor of Glutamate Transporter EAAT2, and It Mediates Manganese-Induced Decrease of EAAT2 Expression in Astrocytes

  2014cites this paper
• Epigenetic Regulation of Individual Modules of the immunoglobulin heavy chain locus 3′ Regulatory Region

  2014cites this paper
• Simulating Hemodynamics in In Vitro Culture Models: Implications on Nano-Biointeractions

  2013cites this paper
• SIMULATING HEMODYNAMICS IN IN VITRO MODELS: IMPLICATIONS ON NANO- BIOINTERACTIONS A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy

  2013cites this paper
• The role of CTCF binding sites in the 3′ immunoglobulin heavy chain regulatory region

  2012cites this paper
• 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Induces Transcriptional Activity of the Human Polymorphic hs1,2 Enhancer of the 3′Igh Regulatory Region

  2012cites this paper
• Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus

  2012cites this paper
• Regulatory Region Igh ′ Polymorphic hs 1 , 2 Enhancer of the 3 Transcriptional Activity of the Human-Dioxin Induces p 2 , 3 , 7 , 8-Tetrachlorodibenzo

  2012cites this paper
• Transcription regulator Yin-yang 1: from silence to cancer.

  2011cites this paper
• The IgH locus 3' regulatory region: pulling the strings from behind.

  2011cites this paper
• Clinical and epidemiological research

  2011cites this paper
• Dynamic Changes in Binding of Immunoglobulin Heavy Chain 3′ Regulatory Region to Protein Factors during Class Switching*

  2011cites this paper
• Raf-1 kinase inhibitor protein modulation of the cellular response to chemotherapeutic drugs and PDE5 inhibitors.

  2011cites this paper
• The long winding road toward understanding the molecular mechanisms for B-cell suppression by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

  2011cites this paper
• TCDD-induced modulation of the hs1,2 enhancer within the 3’immunoglobulin heavy chain regulatory region

  2009cites this paper
• C-Myc et lymphomagenèse dans les cellules B infectées par le virus d’Epstein-Barr

  2009influential citation
• The NF-κB Canonical Pathway Is Involved in the Control of the Exonucleolytic Processing of Coding Ends during V(D)J Recombination1

  2008cites this paper
• NF-κB Regulation of YY1 Inhibits Skeletal Myogenesis through Transcriptional Silencing of Myofibrillar Genes

  2007cites this paper
• Molecular cloning of a structural homolog of YY1AP, a coactivator of the multifunctional transcription factor YY1

  2007cites this paper
• Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis: up-regulation of DR5 and inhibition of Yin Yang 1

  2007cites this paper
• Antiallergic drugs, azelastine hydrochloride and epinastine hydrochloride, inhibit ongoing IgE secretion of rat IgE-producing hybridoma FE-3 cells.

  2006cites this paper
• Transcription factor YY1: structure, function, and therapeutic implications in cancer biology

  2006cites this paper
• Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression

  2006cites this paper
• NF-kappa B activation as a pathological mechanism of septic shock and inflammation.

  2006cites this paper
• NF-κB activation as a pathological mechanism of septic shock and inflammation

  2006cites this paper
• Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.

  2006cites this paper
• Multifunctional transcription factor YY1: a therapeutic target in human cancer?

  2006cites this paper
• Comparative analysis of human and mouse 3' Igh regulatory regions identifies distinctive structural features.

  2005cites this paper
• Evolution of human IgH3'EC duplicated structures: both enhancers HS1,2 are polymorphic with variation of transcription factor's consensus sites.

  2005cites this paper
• Chromatin Architecture near a Potential 3′ End of the Igh Locus Involves Modular Regulation of Histone Modifications during B-Cell Development and In Vivo Occupancy at CTCF Sites

  2005cites this paper
• The HoxC4 Homeodomain Protein Mediates Activation of the Immunoglobulin Heavy Chain 3′ hs1,2 Enhancer in Human B Cells

  2004cites this paper